Differences in Pathogenicity and Vaccine Resistance Discovered between Two Epidemic Strains of Marek's Disease Virus in China

Viruses. 2023 Apr 11;15(4):945. doi: 10.3390/v15040945.

Abstract

Despite highly effective vaccines, Marek's disease (MD) causes great economic loss to the poultry industry annually, largely due to the continuous emergence of new MD virus (MDV) strains. To explore the pathogenic characteristics of newly emerged MDV strains, we selected two strains (AH/1807 and DH/18) with clinically different pathotypes. We studied each strain's infection process and pathogenicity and observed differences in immunosuppression and vaccine resistance. Specific pathogen-free chickens, unvaccinated or vaccinated with CVI988, were challenged with AH/1807 or DH/18. Both infections induced MD damage; however, differences were observed in terms of mortality (AH/1807: 77.8%, DH/18: 50%) and tumor rates (AH/1807: 50%, DH/18: 33.3%). The immune protection indices of the vaccine also differed (AH/1807: 94.1, DH/18: 61.1). Additionally, while both strains caused interferon-β and interferon-γ expression to decline, DH/18 infection caused stronger immunosuppression than AH/1807. This inhibition persisted even after vaccination, leading to increased replication of DH/18 that ultimately broke through vaccine immune protection. These results indicate that both strains have different characteristics, and that strains such as DH/18, which cause weaker pathogenic damage but can break through vaccine immune protection, require further attention. Our findings increase the understanding of the differences between epidemic strains and factors underlying MD vaccination failure in China.

Keywords: IFN-β; IFN-γ; Marek’s disease virus; immunosuppression; pathogenicity; vaccination.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chickens
  • China / epidemiology
  • Herpesvirus 2, Gallid*
  • Marek Disease Vaccines*
  • Marek Disease* / epidemiology
  • Marek Disease* / prevention & control
  • Poultry Diseases* / epidemiology
  • Poultry Diseases* / prevention & control
  • Vaccines*
  • Virulence

Substances

  • Marek Disease Vaccines
  • Vaccines

Grants and funding

This study was supported by the National Natural Science Foundation of China (No. U21A20260, 32170170).